142 related articles for article (PubMed ID: 30836151)
1. Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release.
Nazir I; Asim MH; Dizdarević A; Bernkop-Schnürch A
Int J Pharm; 2019 Apr; 561():197-205. PubMed ID: 30836151
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
Griesser J; Hetényi G; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 Mar; 520(1-2):267-274. PubMed ID: 28188875
[TBL] [Abstract][Full Text] [Related]
3. Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing.
Asad M; Rasul A; Abbas G; Shah MA; Nazir I
PLoS One; 2023; 18(6):e0286668. PubMed ID: 37294790
[TBL] [Abstract][Full Text] [Related]
4. Counterion optimization for hydrophobic ion pairing (HIP): Unraveling the key factors.
Claus V; Sandmeier M; Hock N; Spleis H; Lindner S; Kalb M; Bernkop-Schnürch A
Int J Pharm; 2023 Nov; 647():123507. PubMed ID: 37848166
[TBL] [Abstract][Full Text] [Related]
5. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis.
Chamieh J; Domènech Tarrat A; Doudou C; Jannin V; Demarne F; Cottet H
Int J Pharm; 2019 Mar; 559():228-234. PubMed ID: 30703502
[TBL] [Abstract][Full Text] [Related]
6. Imine bond formation as a tool for incorporation of amikacin in self-emulsifying drug delivery systems (SEDDS).
Dizdarević A; Marić M; Shahzadi I; Ari Efiana N; Matuszczak B; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2021 May; 162():82-91. PubMed ID: 33737147
[TBL] [Abstract][Full Text] [Related]
7. Imine bond formation: A novel concept to incorporate peptide drugs in self-emulsifying drug delivery systems (SEDDS).
Dizdarević A; Efiana NA; Phan TNQ; Matuszczak B; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2019 Sep; 142():92-100. PubMed ID: 31176724
[TBL] [Abstract][Full Text] [Related]
8. Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs.
Bonengel S; Jelkmann M; Abdulkarim M; Gumbleton M; Reinstadler V; Oberacher H; Prüfert F; Bernkop-Schnürch A
J Control Release; 2018 Mar; 273():21-29. PubMed ID: 29355620
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic Ion Pairing of Small Molecules: How to Minimize Premature Drug Release from SEDDS and Reach the Absorption Membrane in Intact Form.
Spleis H; Federer C; Claus V; Sandmeier M; Bernkop-Schnürch A
ACS Biomater Sci Eng; 2023 Mar; 9(3):1450-1459. PubMed ID: 36786693
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione.
Hetényi G; Griesser J; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 May; 523(1):357-365. PubMed ID: 28347848
[TBL] [Abstract][Full Text] [Related]
11. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
[TBL] [Abstract][Full Text] [Related]
12. Self-emulsifying drug delivery systems: In vivo evaluation of their potential for oral vaccination.
Lupo N; Tkadlečková VN; Jelkmann M; Laffleur F; Hetényi G; Kubová K; Bernkop-Schnürch A
Acta Biomater; 2019 Aug; 94():425-434. PubMed ID: 31228632
[TBL] [Abstract][Full Text] [Related]
13. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
[TBL] [Abstract][Full Text] [Related]
14. Solidification of self-emulsifying drug delivery systems (SEDDS): Impact on storage stability of a therapeutic protein.
Friedl JD; Jörgensen AM; Le-Vinh B; Braun DE; Tribus M; Bernkop-Schnürch A
J Colloid Interface Sci; 2021 Feb; 584():684-697. PubMed ID: 33234314
[TBL] [Abstract][Full Text] [Related]
15. Comparative Analysis of PEG-Free and PEG-Based Self-Emulsifying Drug Delivery Systems for Enhanced Oral Bioavailability of Therapeutic (Poly) Peptides.
Haddadzadegan S; To D; Matteo Jörgensen A; Wibel R; Laffleur F; Bernkop-Schnürch A
Small; 2024 Feb; ():e2307618. PubMed ID: 38308358
[TBL] [Abstract][Full Text] [Related]
16. Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro.
Malkawi A; Jalil A; Nazir I; Matuszczak B; Kennedy R; Bernkop-Schnürch A
Mol Pharm; 2020 Oct; 17(10):3709-3719. PubMed ID: 32841038
[TBL] [Abstract][Full Text] [Related]
17. Cosolvents in Self-Emulsifying Drug Delivery Systems (SEDDS): Do They Really Solve Our Solubility Problems?
Jörgensen AM; Friedl JD; Wibel R; Chamieh J; Cottet H; Bernkop-Schnürch A
Mol Pharm; 2020 Sep; 17(9):3236-3245. PubMed ID: 32658482
[TBL] [Abstract][Full Text] [Related]
18. Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases.
Leonaviciute G; Zupančič O; Prüfert F; Rohrer J; Bernkop-Schnürch A
Int J Pharm; 2016 Jul; 508(1-2):102-8. PubMed ID: 27143595
[TBL] [Abstract][Full Text] [Related]
19. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?
Phan TNQ; Le-Vinh B; Efiana NA; Bernkop-Schnürch A
J Drug Target; 2019 Nov; 27(9):1017-1024. PubMed ID: 30776924
[No Abstract] [Full Text] [Related]
20. Development of Fluorescently Labeled Self-Emulsifying Drug Delivery Systems (SEDDS) for Prolonged Stability, In Vitro Sustained Release, and Cellular Uptake.
Malkawi AS; Haddad R; Malkawi A; Alrabadi N
Pharm Nanotechnol; 2022; 10(2):146-161. PubMed ID: 35289258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
